secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-07-09T23:59:59+00:00
Accession:  0001641172-25-018313
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio appoints Emil Chuang to board; Fischbein resigns
-------------------------------------------------------------

- Margery Fischbein resigned from board effective July 2, 2025; no disagreement with company.
- Board accelerated vesting of Fischbein's 3,100 outstanding stock options to fully vested.
- Emil Chuang, MB BS FRACP, appointed to board effective July 7, 2025; also joins audit, compensation, governance committees.
- Chuang is a pediatric gastroenterologist with nearly 25 yrs experience, contributed to two NDA/sBLA approvals.
- Chuang granted non-statutory stock option to purchase 8,000 shares at closing price on grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/0001641172-25-018313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer